Table 1

SSX mRNA expression in gynecological cancers.

  Endometrial cancer Ovarian cancer Cervical cancer
SSX1 1/50 (2%) 0/40 (0%) 1/25 (4%)
SSX2 2/50 (4%) 1/40 (3%) 1/25 (4%)
SSX4 12/50 (24%) 5/40 (13%) 5/25 (20%)